Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Vajdic CM, van Leeuwen MT . What types of cancers are associated with immune suppression in HIV? Lessons from solid organ transplant recipients. Curr Opin HIV AIDS 2009; 4: 35–41.

    Article  Google Scholar 

  2. Law GR . Invited commentary: do clusters of leukemia and lymphoma provide evidence for an infectious cause? Am J Epidemiol 2005; 162: 823–824.

    Article  Google Scholar 

  3. Ben-Bassat I, Raanani P, Gale RP . Graft-versus-leukemia in chronic lymphocytic leukemia. Bone Marrow Transplant 2007; 39: 441–446.

    Article  CAS  Google Scholar 

  4. Ritgen M, Bottcher S, Stilgenbauer S, Bunjes D, Schubert J, Cohen S et al. Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial. Leukemia 2008; 22: 1377–1386.

    Article  CAS  Google Scholar 

  5. Krackhardt AM, Witzens M, Harig S, Hodi FS, Zauls AJ, Chessia M et al. Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX. Blood 2002; 100: 2123–2131.

    Article  CAS  Google Scholar 

  6. Khouri IF, Saliba RM, Admirand J, O’Brien S, Lee MS, Korbling M et al. Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia. Br J Haematol 2007; 137: 355–363.

    Article  CAS  Google Scholar 

  7. Penn DJ, Damjanovich K, Potts WK . MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc Natl Acad Sci USA 2002; 99: 11260–11264.

    Article  CAS  Google Scholar 

  8. Thursz MR, Thomas HC, Greenwood BM, Hill AV . Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 1997; 17: 11–12.

    Article  CAS  Google Scholar 

  9. Doherty PC, Zinkernagel RM . Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature 1975; 256: 50–52.

    Article  CAS  Google Scholar 

  10. Therodorou I, Abel L, Mauro F, Duprey B, Magnac C, Payelle-Brogard B et al. High occurrence of DRB1 11 in chronic lymphocytic leukaemia families. Br J Haematol 2002; 119: 713–715.

    Article  Google Scholar 

  11. Hojjat-Farsangi M, Jeddi-Tehrani M, Amirzargar A, Razavi SM, Sharifian RA, Rabbani H et al. Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia. Hum Immunol 2008; 69: 666–674.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W K Decker.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shah, N., Decker, W., Lapushin, R. et al. HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance. Leukemia 25, 1036–1039 (2011). https://doi.org/10.1038/leu.2011.30

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2011.30

This article is cited by

Search

Quick links